Tutzing, Germany

Christa Hubner-Parajsz


Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1988-2003

Loading Chart...
13 patents (USPTO):

Title: **Christa Hubner-Parajsz: Innovator in Antibody Research**

Introduction

Christa Hubner-Parajsz, based in Tutzing, Germany, is a distinguished inventor with a remarkable portfolio that includes 13 patents. Her contributions to the field of biomedical research, particularly in monoclonal antibodies, have paved the way for advancements in diagnostic methods and treatments.

Latest Patents

Among her latest patents is a significant innovation in the area of antibody development: "Monoclonal antibodies against a human act and serine protease complex." This invention focuses on monoclonal antibodies that target the complex of human ACT and serine protease, specifically ACT-PSA. These antibodies exhibit minimal cross-reactivity with free, non-complexed human ACT and PSA. Additionally, she has developed diagnostic test methods that utilize these monoclonal antibodies to identify serine protease-ACT complexes.

Another noteworthy patent is related to "Antibodies against hepatitis G virus and their use for the diagnostic." This invention involves an antibody targeting a hepatitis G virus antigen and its fragments, alongside the creation of hybridoma cell lines and a conjugate that integrates the antibody or its fragment with a biological molecule. These advances are crucial for the diagnostic detection of hepatitis G virus.

Career Highlights

Christa has contributed to prominent companies such as Boehringer Mannheim GmbH and Roche Diagnostics GmbH, where her research has significantly impacted the development of diagnostic tools. Her expertise in the field has solidified her reputation as a leading figure in antibody research.

Collaborations

Throughout her career, Christa has collaborated with esteemed professionals like Ulrich Essig and Hartmut Schetters. These partnerships have enabled her to refine her inventions and contribute to groundbreaking advancements in biotechnology.

Conclusion

Christa Hubner-Parajsz's innovative work with monoclonal antibodies exemplifies the importance of research in the biomedical field. Her patents not only advance scientific understanding but also hold potential for significant improvements in diagnostic methods and therapeutic interventions. As she continues to build upon her legacy of innovation, the impact of her contributions will undoubtedly resonate in the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…